Envisagenics Expands Executive Leadership with the Appointment of Sudhir Rao as Chief Business Officer

NEW YORK, Feb. 13, 2025 /PRNewswire/ — Envisagenics, an AI-driven biotechnology company revolutionizing RNA splicing research and therapeutics, has appointed Sudhir Rao, M.S., MBA as Chief Business Officer (CBO) to expand and strengthen its leadership team. Mr. Rao’s extensive leadership…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.